ReShape Lifesciences Inc. (RSLS) Financials

$4.56

south_east -$0.19 (-4%)
Day's range
$4.56
Day's range
$4.75

RSLS Income statement / Annual

Last year (2023), ReShape Lifesciences Inc.'s total revenue was $8.68 M, a decrease of 22.79% from the previous year. In 2023, ReShape Lifesciences Inc.'s net income was -$11.39 M. See ReShape Lifesciences Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $8.68 M $11.24 M $13.60 M $11.30 M $15.09 M $606,710.00 $1.29 M $786,660.00 $292,000.00 $0.00
Cost of Revenue $3.13 M $4.44 M $5.25 M $5.04 M $5.78 M $164,299.00 $936,386.00 $431,476.00 $125,000.00 $0.00
Gross Profit $5.55 M $6.80 M $8.35 M $6.26 M $9.31 M $442,411.00 $350,768.00 $355,184.00 $167,000.00 $0.00
Gross Profit Ratio 0.64 0.61 0.61 0.55 0.62 0.73 0.27 0.45 0.57 0
Research and Development Expenses $2.32 M $2.54 M $2.52 M $3.50 M $3.12 M $5.72 M $5.78 M $5.17 M $8.14 M $11.03 M
General & Administrative Expenses $10.32 M $17.25 M $24.41 M $10.53 M $17.22 M $19.26 M $25.98 M $0.00 $0.00 $0.00
Selling & Marketing Expenses $7.55 M $14.09 M $9.17 M $4.69 M $4.85 M $5.24 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $17.87 M $31.34 M $33.58 M $15.22 M $22.07 M $19.26 M $25.98 M $17.98 M $19.89 M $14.56 M
Other Expenses $0.00 $11,000.00 $23.50 M $306,000.00 -$1.34 M -$10,643.00 -$652.00 $0.00 $0.00 $0.00
Operating Expenses $20.19 M $33.88 M $36.10 M $18.72 M $25.19 M $24.98 M $31.76 M $23.15 M $28.03 M $25.59 M
Cost And Expenses $23.32 M $38.32 M $41.35 M $23.76 M $30.98 M $25.15 M $32.70 M $23.58 M $28.16 M $25.59 M
Interest Income $0.00 $113,000.00 $832,000.00 $2.05 M $451,000.00 $0.00 $1,066.00 $5,837.00 $1,819.00 $3,331.00
Interest Expense $0.00 $113,000.00 $832,000.00 $2.05 M $451,000.00 $12,378.00 $3,874.00 $4.10 M $939,182.00 $530,222.00
Depreciation & Amortization $154,000.00 $2.15 M $1.97 M $1.67 M $894,000.00 $581,000.00 $330,000.00 $192,000.00 $188,606.00 $188,904.00
EBITDA -$14.49 M -$24.93 M -$60.62 M -$18.10 M -$17.22 M -$36.97 M -$34.39 M -$19.51 M -$27.68 M -$25.40 M
EBITDA Ratio -1.67 -2.22 -2.04 -1.1 -1.14 -39.74 -24.4 -28.97 -103.54 0
Operating Income Ratio -1.69 -2.41 -2.04 -1.1 -1.05 -63.53 -24.4 -28.98 -95.43 0
Total Other Income/Expenses Net $3.30 M -$4.68 M -$12.17 M -$9.35 M -$50.64 M -$167,731.00 -$1.37 M -$565,217.00 $2.37 M -$535,725.00
Income Before Tax -$11.34 M -$46.59 M -$62.04 M -$21.81 M -$75.10 M -$38.71 M -$36.13 M -$23.36 M -$25.50 M -$26.13 M
Income Before Tax Ratio -1.31 -4.15 -4.56 -1.93 -4.98 -63.81 -28.07 -29.7 -87.33 0
Income Tax Expense $52,000.00 -$380,000.00 -$106,000.00 -$181,000.00 -$893,000.00 -$3.45 M -$2.31 M $3.96 M -$2.56 M $347,096.00
Net Income -$11.39 M -$46.21 M -$61.93 M -$21.63 M -$74.21 M -$81.15 M -$33.82 M -$23.36 M -$25.50 M -$26.13 M
Net Income Ratio -1.31 -4.11 -4.55 -1.91 -4.92 -133.76 -26.27 -29.7 -87.33 0
EPS -110.88 -6316.2 -16438.36 -48193.94 -137166.52 -370876.36 -176008.54 -481393.62 -132819.42 0
EPS Diluted -110.88 -6316.2 -16438.36 -48193.94 -137166.52 -370876.36 -176008.54 -481393.62 -132819.42 0
Weighted Average Shares Out $102,699.00 $7,317.07 $3,767.62 $1,346.43 $1,623.00 $218.81 $192.14 $48.53 $191.98 $0.00
Weighted Average Shares Out Diluted $102,699.00 $7,317.07 $3,767.62 $1,346.43 $1,623.00 $218.81 $192.14 $48.53 $191.98 $0.00
Link